Adrenal insufficiency may occur in patients with liver cirrhosis. The assessment of hypothalamus-pituitaryadrenal function is important in such patients, but there is no consensus as to how it should be performed. We herein report the results of our evaluation of the adrenal function in two patients with hypocortisolism accompanied by liver cirrhosis. The patients lacked the typical features of hypocortisolism. One was diagnosed with hypocortisolism accompanied by liver cirrhosis while the other had secondary adrenal insufficiency caused by a hypothalamic disorder. Hypocortisolism accompanied by liver cirrhosis should be evaluated by endocrine tests to determine its pathogenesis. A low-dose adrenocorticotropic hormone test may be appropriate for non-critically ill cirrhotic patients.
Introduction
Adrenal insufficiency has been reported in patients with liver cirrhosis (1, 2) , both in patients with stable cirrhosis and in those with cirrhosis associated with decompensation during sepsis and septic shock (3, 4) . In particular, adrenal insufficiency during sepsis or septic shock is associated with increased mortality in patients with liver cirrhosis (1, 2, 5) . Consequently, hepato-adrenal syndrome has been proposed. Decreases in cholesterol concentrations, which could lead to a lack of substrates, and to the progressive exhaustion of the adrenal reserve have been shown in patients with liver cirrhosis (6, 7) . Additionally, in patients with liver diseases, increased levels of circulating endotoxin and pro-inflammatory cytokines may lead to the impairment of the hypothalamuspituitary-adrenal (HPA) axis or glucocorticoid resistance (2, 8) .
Although it is important to diagnose adrenal insufficiency in critically ill cirrhotic patients in a timely manner, these patients lack features that are typically seen in non-cirrhotic patients with adrenal insufficiency (9, 10) . Generally, over 90% of circulating cortisol is bound to corticosteroidbinding globulin (CBG) and albumin, with less than 10% in the free biologically active form (2) . Serum total cortisol assays may therefore overestimate the adrenal insufficiency of patients with cirrhosis because hypoalbuminemia and low cholesterol (which is a substrate for cortisol) levels, are frequently present in these patients. The assessment of the HPA function in such patients is very important; however, there is no consensus on the appropriate tests and normal values that should be applied to the assessment of the adrenal function in patients with liver disease (2) .
We herein report the cases of two patients liver cirrhosis and diabetes in which hypocortisolism was identified on screening for secondary diabetes. Our evaluation of the adrenal function in these cases revealed different causes of the hypocortisolism: one patient was diagnosed with hypocortisolism accompanied by liver cirrhosis; the other was diagnosed with secondary adrenal insufficiency caused by a hy- 
Case Reports

Case 1
A 53-year-old man with a 10-year history of diabetes mellitus and alcoholic liver cirrhosis was referred to our hospital for the control of his diabetes. He had been treated with oral hypoglycemic agents [pioglitazone (30 mg), alogliptin (25 mg), and glimepiride (1 mg), all once daily]. On admission, his height was 163 cm, his body weight was 77.7 kg, and his blood pressure was 133/80 mmHg. The patitent showed mild ascites and he had no symptoms of hepatic encephalopathy. His Child-Pugh score was grade B, as indicated by a prothrombin time of 23%, an albumin level of 3.2 g/dL, and a total bilirubin level of 1.8 mg/dL (Table 1). His plasma adrenocorticotropic hormone (ACTH) and cortisol levels were measured to screen for secondary diabetes. The patient's plasma ACTH level (17.3 pg/mL) was normal but his plasma cortisol (2.9 μg/dL) was low (Table 2). His CBG level was 22.87 μg/dL (Table 2) . His urinary free cortisol (UFC) levels were 28.6 and 37.4 μg/day, while his salivary free cortisol (SFC) level was 0.29 μg/dL ( Table 2 ). All of the endocrine examinations were performed according to the clinical guidelines, and informed consent for the tests was obtained from the patient. The patient's plasma cortisol level showed no response to a low-dose ACTH test and a normal response to a standard-dose ACTH test. His plasma ACTH level showed an exaggerated response to the human corticotropin-releasing hormone (hCRH) test (Table 3) . Abdominal CT revealed slight atrophy of both adrenal glands (data not shown).
Case 2
A 62-year-old woman with a 20-year history of hepatitis C and a 2-year history of diabetes and liver cirrhosis was referred to our hospital for control of her diabetes. She had been treated with oral hypoglycemic agents [glimepiride (1 mg/day), and voglibose (0.2 mg, t.i.d.)]. On admission, her height was 149 cm, her body weight was 42.7 kg, and her blood pressure was 99/65 mmHg. She did not have ascites or symptoms of hepatic encephalopathy. Her Child-Pugh score was grade A, as indicated by a prothrombin time of 85%, an albumin level of 3.2 g/dL, and a total bilirubin level of 0.6 mg/dL (Table 1) . A screening for secondary diabetes revealed a normal plasma level of ACTH (26.8 pg/mL) but a low plasma level of cortisol (0.87 μg/dL) ( Table 2) . Her CBG level was 38.27 μg/dL, while UFC excretion was undetectable and her SFC level was 0.34 μg/dL ( Table 2 ). All endocrine examinations were performed according to the clinical guidelines, and informed consent for the tests was obtained from the patient. The patient's plasma cortisol level showed no response to a low-dose ACTH test, a normal response to a standard-dose ACTH test, and no response to a hCRH test. Furthermore, his plasma cortisol and ACTH levels showed no response to an insulin tolerance test (Table 3). Pituitary MRI found no clear presence of a pituitary adenoma or shift of the pituitary stalk, while abdominal CT revealed the slight atrophy of both adrenal glands (data not shown).
Discussion
We herein described two different cases of hypocortisolism accompanied by liver cirrhosis. Case 1 showed a low basal level of plasma cortisol and a lower normal level of UFC, but a normal level of SFC, while the CBG level was at the lower end of the normal range. Case 1 had the typical features of adrenal insufficiency in a patient with liver cirrhosis. In contrast, Case 2 showed a very low basal level of plasma cortisol and an undetectable level of UFC, but a normal level of SFC, while the CBG level was within the normal range. The patient's plasma cortisol and ACTH levels did not increase after the insulin tolerance test. Thus, Case 2 did not have the typical features of hypocortisolism in the setting of liver cirrhosis and her secondary adrenal insuffi- ciency was presumably caused by a hypothalamic disorder. The patient had a traffic accident approximately 20 years prior to her presentation, but it is unclear whether this previous incident was associated with her disorder. A discrepancy between UFC and SFC levels was observed in this case. The SFC levels could be considered to be high, because the levels of other cortisol markers were very low or undetectable, presumably due to the secondary adrenal insufficiency. Decreased local expression levels of 11β-hydroxysteroid dehydrogenase type 2 are known to elevate local free cortisol levels. However, this may not have happened in Case 2 and it is unclear what factors are involved in the elevation of her SFC levels. Taken together, our findings suggest that hypocortisolism accompanied by liver cirrhosis should be evaluated by additional endocrine tests to elucidate its pathogenesis. Cortisol, which exists in both free (active) and proteinbound forms in the blood, but only in free form in saliva, is an important steroid for the regulation of the stress response. CBG levels in blood are generally decreased in patients with liver cirrhosis. Low levels of CBG cause low levels of total cortisol and thus adrenal insufficiency may be overestimated. The measurement of serum free cortisol is not available on a commercial basis in Japan. Salivary cortisol sampling has been found to be useful for assessing the HPA axis (11) and evaluating the level of endogenous free cortisol (12, 13) . In fact, salivary cortisol concentrations are directly proportional to the concentration of serum unbound cortisol (14) . Galbois et al. suggested that the salivary cortisol level is a more appropriate measure for the clinical assessment of adrenal function in cirrhotic patients (15) .
The ACTH test is the standard test to assess adrenal insufficiency. Although there is no consensus on the diagnostic criteria of adrenal insufficiency in cirrhotic patients, the normal cortisol response is considered to be >18 μg/dL. Recent reports have shown that plasma cortisol levels in cases with mild adrenal insufficiency are only increased by the standard-dose ACTH test, and not by the low-dose ACTH test (16) . The plasma cortisol levels did not increase in either of our cases after the low-dose ACTH test but were increased after the standard-dose ACTH test. Accordingly, the low-dose ACTH test seems to be a more physiological and sensitive test than the standard-dose test for the diagnosis of adrenal insufficiency and to be appropriate for use in non-critically ill cirrhotic patients (2, 17) .
It has recently been shown that corticosteroid therapy may have beneficial effects in liver disease patients with sepsis and shock. Fernández et al. evaluated the effects of hydrocortisone treatment in patients with liver cirrhosis and septic shock (9) . Hydrocortisone therapy was found to be associated with significant increases in shock resolution and survival rate (9) . The evaluation of relative adrenal insufficiency might be beneficial due to the potential of hydrocortisone therapy when such cases arise. Fede et al. proposed that the low-dose ACTH test may be appropriate for patients with cirrhosis without critical illness, while the standarddose ACTH test could be better for patients with liver disease and acute decompensation (2) .
With respect to treatment, replacement therapy with glucocorticoids was not given in Case 1, because his UFC and SFC levels were within the normal basal ranges. Corticosteroid therapy would have been considered in stressful conditions. On the other hand, hydrocortisone (10 mg/day) was administered to Case 2, due to an undetectable level of UFC, which was complicated with secondary adrenal insufficiency. The patient had no complaints or symptoms before the treatment. After the treatment, there were no remarkable changes in her laboratory data, including her hemoglobin A1c, and physical condition. It would be very useful to determine an appropriate treatment modality for patients with liver dysfunction accompanied by subclinical or relative adrenal insufficiency. In order to address whether hydrocortisone replacement improves the long-term prognosis and eventual mortality, a careful follow-up will be required in Case 2. Further studies and evidence will need to be accumulated in order to determine the most appropriate treatment for patients with liver cirrhosis.
We herein reported the different causes of hypocortisolism and suggest that hypocortisolism accompanied by liver cirrhosis may be evaluated by additional endocrine tests to elucidate its pathogenesis. A low-dose ACTH test may be appropriate for non-critically ill cirrhotic patients.
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